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Background: Patients often seek other patients’ experiences with the disease. The Internet provides a wide range of opportunities
to share and learn about other people’s health and illness experiences via blogs or patient-initiated online discussion groups. There
also exists a range of medical information devices that include experiential patient information. However, there are serious
concerns about the use of such experiential information because narratives of others may be powerful and pervasive tools that
may hinder informed decision making. The international research network DIPEx (Database of Individual Patients’ Experiences)
aims to provide scientifically based online information on people’s experiences with health and illness to fulfill patients’ needs
for experiential information, while ensuring that the presented information includes a wide variety of possible experiences.
Objective: The aim is to evaluate the colorectal cancer module of the German DIPEx website krankheitserfahrungen.de with
regard to self-efficacy for coping with cancer and patient competence.
Methods: In 2015, a Web-based randomized controlled trial was conducted using a two-group between-subjects design and
repeated measures. The study sample consisted of individuals who had been diagnosed with colorectal cancer within the past 3
years or who had metastasis or recurrent disease. Outcome measures included self-efficacy for coping with cancer and patient
competence. Participants were randomly assigned to either an intervention group that had immediate access to the colorectal
cancer module for 2 weeks or to a waiting list control group. Outcome criteria were measured at baseline before randomization
and at 2 weeks and 6 weeks
Results: The study randomized 212 persons. On average, participants were 54 (SD 11.1) years old, 58.8% (124/211) were
female, and 73.6% (156/212) had read or heard stories of other patients online before entering the study, thus excluding any
influence of the colorectal cancer module on krankheitserfahrungen.de. No intervention effects were found at 2 and 6 weeks after
baseline.
Conclusions: The results of this study do not support the hypothesis that the website studied may increase self-efficacy for
coping with cancer or patient competencies such as self-regulation or managing emotional distress. Possible explanations may
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involve characteristics of the website itself, its use by participants, or methodological reasons. Future studies aimed at evaluating
potential effects of websites providing patient experiences on the basis of methodological principles such as those of DIPEx might
profit from extending the range of outcome measures, from including additional measures of website usage behavior and users’
motivation, and from expanding concepts, such as patient competency to include items that more directly reflect patients’ perceived
effects of using such a website.
Trial Registration: Clinicaltrials.gov NCT02157454; https://clinicaltrials.gov/ct2/show/NCT02157454 (Archived by WebCite
at http://www.webcitation.org/6syrvwXxi)
(J Med Internet Res 2017;19(10):e334)   doi:10.2196/jmir.7639
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Introduction
Activating patients to become partners in their care has been a
priority in health policy in many Western countries over the
past years [1]. Increasing patient participation in health care
rests, however, on at least three interrelated prerequisites. First,
information on disease, treatments, and outcomes should be
widely available. Second, health care providers should be able
to effectively convey this information to patients and enable
them to make informed decisions. Third, patients should be able
to access, process, decide, and act on the health information
relevant to them. As a consequence, interest has grown in
concepts that describe patients’ abilities to acquire and process
health information, such as empowerment [2-5], health literacy
[6-9], patient competence [10], and self-efficacy in coping with
cancer [11-13] and other chronic diseases [14,15]. Obviously,
the importance of these concepts can be rated even more highly
if one considers the opportunities that the Internet provides for
disseminating health information.
Although medical information on diseases, treatments, and
outcomes that is based on available quality criteria [16-19]
represents an important input into patients’ informed (treatment)
decision making, patients facing health care decisions also seek
and use experiential information describing how other patients
live with a disease [20-22]. This field of experiential knowledge
and its presentation has recently received increasing attention
in research on health information resources. Here again, the
Internet provides a wide range of opportunities to share and
learn about other people’s health and illness experiences via
blogs or patient-initiated online discussion groups, which may
provide support from peers [5,23]. Some peer-to-peer online
tools have been shown to increase patient empowerment in
relation to information, mental health, and feeling supported
[24,25], whereas others have revealed mixed or negative effects
[5]. In addition, there exists a range of medical information
devices that include experiential patient information, including
decision aids [26] and other health information venues [27,28].
However, there is serious concern about the use of narratives
in health information because they are powerful and persuasive
tools and they may unduly influence health care decision making
[29-33].
Against this background, this study asks whether a website that
provides experiential information on living with colorectal
cancer based on scientifically rigorous data collection and
analysis positively influences self-efficacy for coping with
cancer [11-15] and patient competence [10]. It aims to evaluate
potential effects of a specifically designed website, while at the
same time providing insight into factors contributing to changes
in coping self-efficacy and patient competence that are
increasingly attracting more research interest in psycho-oncology
[10,34]. More specifically, we hypothesized that, compared to
a waiting list control group, having access to and using a website
presenting a broad range of individual experiences with
colorectal cancer would increase patients’ perceived self-efficacy
for coping with cancer and patient competencies such as the
ability to manage emotional distress arising in the context of
cancer and its treatment or self-regulation as an ability to




The study used a randomized two-group between-subjects design
with repeated measures; participants were randomly assigned
either to an intervention group that had immediate access to the
colorectal cancer module for 2 weeks or to a waiting list control
group that was given access to the module after completion of
the study 6 weeks after randomization. Coping self-efficacy
served as the primary outcome; patient competencies constituted
the secondary outcome. Outcome criteria were measured in both
groups at baseline before randomization and at 2 weeks (time
1). At 6 weeks after baseline (time 2), follow-up measures were
taken to test for the short-term stability of the intervention. The
trial was conducted before the website became available to the
general public.
The study protocol was approved by the Charité
Universitätsmedizin Berlin ethics committee (EA4/053/12) and
was registered (clinicaltrials.gov NCT02157454). This trial is
reported according to the Consolidated Standards of Reporting
Trials (CONSORT) statement and the CONSORT-EHEALTH
extension.
Intervention
The intervention of the study consisted of a website providing
information of experiences by men and women diagnosed with
colorectal cancer. The website is a section (module) of a German
website krankheitserfahrungen.de, which aims to provide
scientifically collected and analyzed experiences of health and
illness to patients, health care providers, and the wider public.
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The project team DIPEx Germany that runs the website is a
member of the international research network DIPEx (Database
of Individual Patients’ Experiences) [35]. The website is hosted
at the University of Freiburg. DIPEx aims to present online
information on people’s experiences with health and illness that
have been systematically collected through qualitative interviews
and analyzed with rigorous qualitative research methods. DIPEx
intends to fulfill patients’ needs for experiential information,
while ensuring that the presented information includes a wide
variety of possible experiences with the disease [36]. This is
achieved by collecting illness experiences employing a
maximum variation sampling strategy and using narrative
interviewing techniques [37]. A researcher handbook details
how the experiences are to be collected and analyzed. The
handbook also ensures that funding for modules may only be
provided by organizations with no involvement or financial
interests in the content. This systematic and scientific approach
and the transparency regarding funding distinguishes DIPEx
markedly from peer-to-peer and other online support resources.
The content of the modules of the DIPEx website can be
accessed via thematic pages (eg, “stoma” or “living with
colorectal cancer”) or by interviewed persons (person pages).
The person pages can be searched applying a filter (eg, age or
gender) for ease of navigation. These features of the website
are positively viewed by users [37-39]. In particular, the feature
that one may find others who are similar to oneself seems to
help users find hope [37].
Sample Size and Power Calculation
In determining the necessary sample size for the trial, it was
assumed that given a standard deviation of 18 [40,41], a
difference of five scale points in self-efficacy for coping with
cancer between the intervention group and the waiting list
control group could be reasonably expected and should be
detected with a power of .80 and a type one error probability
of alpha=.05. For Cohen's d (between-group mean difference
divided by SD) [42], this lies in the range of a small effect size
(d=.20-.49). Based on these premises, a sample size of n=205
participants per group was deemed necessary.
Eligibility Criteria
Potential participants were considered eligible if they were
German-speaking, 18 years of age or older, and had either been
diagnosed with colorectal cancer within the past 3 years before
enrollment or—independent of time since diagnosis—had
metastasized colorectal cancer and/or a relapse of the disease,
and who consented to participate online on the study website.
Potential participants who indicated on the survey that the time
since their diagnosis was more than 3 years and who indicated
that they had no recurrence or metastases were excluded from
the study.
Recruitment and Enrollment
A wide range of recruitment strategies was used. Many major
websites related to colorectal cancer, such as
felix-burda-stiftung.de and lebensblicke.de, were informed about
the study and provided a link to the study website. Information
on the study was posted regularly on a colorectal cancer
Facebook group and on online colorectal cancer discussion
groups. The study was presented in-person to support groups,
in rehabilitation clinics, and to hospital staff for them to aid in
recruitment. Some colorectal cancer centers also informed their
patients about the study. Finally, the project was presented at
information events for patients at hospitals and cancer meetings.
Recruitment started in June 2014 and ended in August 2015.
Study participants had to enroll themselves through the study
website, which also provided detailed information about the
study. If participants then chose to enroll, this was considered
as giving consent because they had previously been informed.
After enrollment, participants were first asked to complete the
baseline measures and were then randomized.
Data Collection
Online data collection at the three measurement points required
patients to complete validated questionnaire measures of
self-efficacy for coping with cancer, patient competence,
depression, social support, health-related quality of life, and
medical information received (Table 1). In addition, information
on selected sociodemographic, illness, and treatment
characteristics was obtained at baseline. Participants were also
asked to provide information on their use of Internet resources
addressing issues related to colorectal cancer. The pages that
each participant visited on the intervention website were logged
along with a time stamp, thus allowing a determination of the
amount of time they spent on the website (in minutes), the
number of sessions using the site, and the number of clicks
produced (as an indicator of the number of subpages accessed).
The analyses reported here focus primarily on the results
regarding self-efficacy for coping with cancer and patient
competence.
Primary Outcome: Self-Efficacy for Coping With
Cancer
Self-efficacy for coping with cancer may be defined as a
patient’s confidence in his or her ability to perform coping
behaviors in the context of cancer [13]. As the primary outcome
of this study, self-efficacy for coping with cancer was measured
using the German version of the brief form of the Cancer
Behavior Inventory (CBI-B-D) [40,43]. Like the CBI-B, the
original version of this instrument [11,13], the CBI-B-D consists
of 14 items that describe coping behaviors in the context of
cancer. Patients are asked to rate how confident they are in
performing each of these behaviors on a nine-point scale ranging
from “not at all confident” to “totally confident.” A summary
score is obtained across all 14 items, which can range from 14
to 126, with high values indicating high confidence in one’s
ability to perform the coping behaviors. The German version
was created using a forward-backward translation approach.
Reliability estimates for both the original and the German
versions of the scale are generally high. Furthermore, the validity
of the scale has been demonstrated in various studies of
concurrent, predictive, or construct validity [11,13]. The
CBI-B-D score was measured at baseline and at 2 and 6 weeks
postbaseline.
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Table 1. Data collection: measurements and time points.
6 weeks after
randomization
2 weeks into study
(postintervention)
BaselineVariables measureda
XSociodemographics; illness and treatment characteristics; Internet use behavior
XDepression: PHQ-2
XSocial support: SSUK-8
XXXSelf-efficacy for coping with cancer: CBI-B-D (primary outcome)
4 subscales4 subscalesAll 8 subscalesSelf-ratings of patient competencies: FEPK 2-57 (secondary outcome)
XInformation: EORTC QLQ-INFO25
XXRatings of personal reports of those affected by cancer
XQuality of life: EORTC QLQ-C30
aCBI-B-D: German version of brief form of Cancer Behavior Inventory; EORTC QLQ-C30: questionnaire to assess the quality of life of cancer patients
by the European Organisation for Research and Treatment of Cancer; EORTC QLQ-INFO25: questionnaire to assess information given to cancer
patients; FEPK 2-57: 57-item questionnaire on patient competence using five problem-focused and three emotion-focused subscales; PHQ-2: two-item
Patient Health Questionnaire; SSUK-8: German brief version of the illness-specific Social Support Scale.
Secondary Outcome: Patient Competence
Following Giesler and Weis [10], patient competence in the
context of cancer may be understood as a patient’s ability to
deal with the tasks and distress arising from cancer and its
treatment, to be guided by his or her personal needs and goals,
and to make use of support available from significant others or
from the health care system as a whole. Based on this working
definition of patient competence, as well as factor analysis, they
constructed a self-rating measure of patient competence (FEPK
2-57) that assesses five problem-focused and three
emotion-focused competencies. The measure contains 57 items
each rated on a five-point scale intended to measure behaviors
indicative of patient competence as determined in prior pilot
studies. Items addressing emotion-focused competencies offer
the additional response option of “not applicable to me.”
Subscale internal consistencies (Cronbach alpha) range from
.64 to .87 (median .77) and may be judged as at least
satisfactory. In this study, all these competencies were measured
at baseline. At weeks 2 and 6, however, only the three
emotion-focused competencies and one of the problem-focused
competencies were measured as secondary outcomes because
they were considered to best reflect the potential effects of the
website.
The competencies measured at baseline and weeks 2 and 6 were
“self-regulation” (ability to negotiate needed support and to
allow for resting periods during the course of the day when
needed), “managing distressing emotions” (ability to deal with
cancer-related fears), “dealing explicitly with the threat posed
to life by cancer” (being able to confront the idea that one might
die), and “(low) avoidance” (ability not to engage in ruminating
thoughts and avoidance behaviors) [10]. Problem-focused
competencies measured only at baseline were “seeking
information concerning disease and treatment,” “being assertive
in interactions with physicians,” “striving for autonomous
decisions,” and “interest in social services.” Scale scores for all
competencies were formed by computing a participant’s
individual mean across the respective items. Scores can vary
between 1 and 5, with higher scores indicating a higher level
of self-rated competence.
Additional Measures
To allow a more comprehensive characterization of the
participants, depression, social support, quality of life, and
satisfaction with information received on the condition and its
treatment were measured. Depression was measured at baseline
using the two-item Patient Health Questionnaire (PHQ-2)
[44,45]. Also at baseline, social support was measured by means
of the SSUK-8 [46], the brief form of the German adaptation
of the illness-specific Social Support Scale (SSUK) [47]. At 2
weeks, health-related quality of life was measured with the
QLQ-C30, a reliable and valid instrument developed by the
European Organisation for Research and Treatment of Cancer
(EORTC) [48]. Finally, respondents’ evaluation of disease and
treatment information received was measured with the EORTC
QLQ-INFO25 [49] at 2 weeks.
Data Analysis
Data analysis was performed using IBM SPSS versions 23 and
24. Baseline differences between the intervention and the
waiting list group were analyzed by means of chi-square
statistics for categorical variables or one-way analyses of
variance (ANOVAs) in the case of continuous variables based
on all participants with nonmissing data for a given variable.
Effect sizes were estimated by computing phi coefficients or
eta squared. Following Cohen [42], these may be categorized
as small, medium, or large, with values of .10, .30, and .50
representing corresponding effect size thresholds for the phi
coefficient, and values of .01, .06, and .14 representing those
for eta squared.
For testing the hypothesized intervention effect on the primary
and secondary outcomes, we preformed separate regression
analyses of the postintervention (week 2) and follow-up (week
6) scores with the intervention dummy coded (intervention=0,
control=1) and the respective pretest scores as an additional
predictor, which is equivalent to a traditional analysis of
covariance. These analyses were based on all randomized
participants, using multiple imputation of missing values at
baseline and at 2 and 6 weeks. We ran 10 multiple imputations
with the full information maximum likelihood method when
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data were missing in single items or scales. Multiple imputation
creates multiple datasets, in which the missing observations are
imputed, using a stochastic algorithm that estimates values based
on given information and creates different imputed values in
each dataset. Statistics are performed separately for these
datasets and coefficients are combined after having finished the
analyses [50]. The assumption that data were missing completely
at random could be retained after performing Little’s missing
completely at random test [51], which was not significant with
χ231,997=27,222.8 (P>.99). The effect sizes of the predictors in
the regression models are reported as beta weights for which
the minima and maxima across the analyzed imputed datasets
will be given. Following Cohen [42], values of .10, .30, and .50
for beta represent the thresholds for interpreting effects as small,
medium, or large, respectively.
Results
Sample Characteristics at Baseline
The sample consisted of 212 randomized participants who
completed the baseline survey. Figure 1 shows the participant
flow.
The mean age of participants was 54.1 (SD 11.1) years and
58.8% (124/211) were female. Approximately 73.6% (156/212)
of the study sample had read or heard stories and experiences
of other patients online before that were unrelated to the
intervention provided in the study. Most participants were
recruited via the Internet (123/212, 58.0%), 33 (15.6%) were
referred to the website by their physician, 25 (11.8%) were
recruited via flyers, 8 (3.8%) had been informed by friends, and
23 (10.8%) provided no information about their recruitment
path.
Figure 1. Flowchart of study participation.
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.5753.6 (10.5)54.5 (11.8)Age in years, mean (SD)
.19Family status, n (%)
82 (75.2)85 (82.5)With partner








.06Professional training, n (%)
1 (0.9)8 (7.8)No degree
53 (49.5)55 (53.9)Vocational training
44 (41.1)33 (32.4)University degree
9 (8.4)6 (5.9)Other
.41Employment status, n (%)
34 (31.2)30 (29.4)Employed
2 (1.8)4 (3.9)Unemployed








aP values for group comparisons are based on one-way ANOVAs for age and on chi-square tests for categorical variables.
As shown in Tables 2 and 3, there were no significant
differences at baseline between intervention and control
participants with respect to sociodemographic or illness and
treatment characteristics. Similarly, there were no differences
between the groups with regard to having sought health
information online before entering the trial, including having
read reports of other patients online (Table 4). Groups also did
not differ significantly at baseline with respect to the primary
and secondary outcomes and depression. However, participants
in the control group tended to experience slightly less positive
social support than those in the intervention group, with an
effect size of eta squared=.02, which would qualify as small
[42].
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Table 3. Illness and treatment characteristics of participants in the intervention and control groups at baseline (N=212).




Illness and treatment characteristics
.07Time since diagnosis
61 (56.0)62 (60.2)<2 years before survey
42 (38.5)28 (27.2)2-3 years before survey

















6 (5.9)5 (5.6)Planned or uncertain




1 (1.6)2 (3.8)Planned or uncertain




4 (3.9)8 (8.2)Planned or uncertain
2 (1.9)1 (1.0)Not received
aP values for group comparisons are based on chi-square tests for categorical variables.
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Table 4. Health information-seeking characteristics and mean scores for patient competence, social support, and depression of participants in the
intervention and control groups at baseline (N=212).
P aControlInterventionPatient characteristics
n=83-109n=71-103Health information-seeking behavior






.62Sought Internet health information, n (%)
101 (98.1)96 (97.0)Yes
2 (1.9)3 (3.0)No
.81Had contact with others affected, n (%)
82 (75.2)76 (73.8)Yes
27 (24.8)27 (26.2)No
.74Participated actively in Internet chats and forums, n (%)
19 (21.3)19 (23.5)Yes
70 (78.7)62 (76.5)No
.87Read Internet reports of others affected before entering trial, n (%)
80 (75.5)76 (74.5)Yes
26 (24.5)26 (25.5)No
.2096.27 (19.71)99.74 (17.20)Self-efficacy for coping with cancer, mean (SD)b
Patient competencies, mean (SD)
n=103-108n=96-103Problem-focused
.734.04 (0.78)4.00 (0.79)Seeking information
.183.48 (0.75)3.61 (0.51)Self-regulation
.404.00 (0.78)4.09 (0.71)Patient-physician interaction
.512.84 (0.89)2.92 (0.82)Autonomous decision
.763.92 (1.38)3.98 (1.42)Interest in social benefits
n=61-94n=58-86Emotion-focused
.143.32 (0.77)3.54 (0.88)Coping with distress
.533.70 (0.72)3.78 (0.56)Dealing with threat
.743.35 (0.80)3.39 (0.78)Low avoidance
.291.81 (1.51)1.58 (1.55)Depression, mean (SD)c
n=102-106n=103-109Social support, mean (SD)
.044.22 (0.78)4.43 (0.62)Positive support
.481.92 (0.70)2.00 (0.77)Distressing interaction
aP values for group comparisons are based on chi-square tests for categorical variables and on one-way ANOVAs for self-efficacy for coping with
cancer, patient competence, depression, and social support.
bIntervention: n=94; control: n=97.
cIntervention: n=101; control: n=105.
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Website Use of Intervention Group
On average, participants in the intervention group visited the
intervention website for mean 42.21 (SD 45.64, median 26)
minutes in total. The mean number of sessions at the site was
3.43 (SD 2.94, median 3). A mean 40.15 (SD 42.14, median
26) clicks across all sessions suggests that the intervention
participants accessed a moderately large number of subpages.
Primary and Secondary Outcomes at Weeks 2 and 6
Table 5 shows the results of the regression analyses of the scores
of the intervention and control group at 2 weeks. As shown by
the unstandardized regression weight for the group factor (b
group), there were no significant differences at 2 weeks between
the intervention and control groups for self-efficacy for coping
with cancer as the primary outcome. Furthermore, no significant
group differences were determined for the secondary outcome
measures of patient competencies, such as self-regulation,
coping effectively with emotional distress, dealing explicitly
with the threat posed by cancer, and low avoidance. The b
coefficients obtained for the respective baseline scores serving
as a covariate were generally significant. The corresponding
effect sizes (expressed as beta weights) ranged from 0.49 to
0.72, thus indicating large effects [42]. The mean scores tended
to be lower at 2 weeks in comparison to baseline (Table 5).
Additional group×time repeated measures ANOVAs of changes
from baseline to 2 weeks showed a generally significant decrease
in all outcome variables except for coping with distress
(unimputed data, F values not shown, for mean values see Table
5). With values of eta squared less than .06, effect sizes were
judged as small [42].
Table 6 presents the results of the regression analyses of the
scores of the intervention and control subjects at time 2. Again,
intervention and control did not differ with respect to the primary
and secondary outcomes as shown by the nonsignificant b
coefficients for the group factor. The size of the significant beta
weights of the baseline scores entered as covariates ranged from
0.46 to 0.70, also suggesting a large effect of the baseline
measure here [42].
Table 5. Results of regression analyses of group effects on primary and secondary outcomes at 2 weeks including the respective baseline score as
additional predictor.








0.74, 0.76<.0010.79–0.07, –0.05.21–2.25Self-efficacy for coping
96.34 (1.29)94.45 (1.94)98.35 (1.66)Baseline




3.53 (0.05)3.48 (0.07)3.58 (0.06)Baseline
3.43 (0.05)3.37 (0.08)3.49 (0.06)Week 2
0.68, 0.72<.0010.64–0.12, –0.07.07–0.13Coping with distress
3.52 (0.05)3.42 (0.07)3.62 (0.08)Baseline
3.39 (0.05)3.27 (0.07)3.53 (0.06)Week 2
0.49, 0.54<.001.50–0.07, –0.03.52–0.05Dealing with threat
3.74 (0.04)3.73 (0.07)3.74 (0.06)Baseline
3.69 (0.04)3.67 (0.06)3.72 (0.06)Week 2
0.66, 0.71<.0010.660.01, 0.04.680.03Low avoidance
3.39 (0.05)3.38 (0.08)3.40 (0.08)Baseline
3.25 (0.05)3.25 (0.07)3.24 (0.07)Week 2
aResults based on 10 multiple imputations, b coefficient combined (mean), beta coefficients as effect size, minimum and maximum across imputations,
group dummy coded with intervention=0, control=1.
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Table 6. Results of regression analyses of group effects on primary and secondary outcomes at 6 weeks including respective baseline scores as additional
predictor.








0.61, 0.64<.0010.62–0.01, 0.01.99–0.00Self-efficacy for coping
96.34 (1.29)94.45 (1.94)98.35 (1.66)Baseline




3.53 (0.05)3.48 (0.07)3.58 (0.06)Baseline
3.47 (0.05)3.48 (0.07)3.46 (0.06)Week 6
0.59, 0.65<.001.53–0.03, 0.02.86–0.01Coping with distress
3.52 (0.05)3.42 (0.07)3.62 (0.08)Baseline
3.44 (0.04)3.38 (0.06)3.50 (0.06)Week 6
0.46, 0.54<.0010.47–0.05, 0.01.75–0.02Dealing with threat
3.74 (0.04)3.73 (0.07)3.74 (0.06)Baseline
3.71 (0.04)3.70 (0.06)3.73 (0.06)Week 6
0.61, 0.67<.0010.61–0.07, 0.01.62–0.04Low avoidance
3.39 (0.05)3.38 (0.08)3.40 (0.08)Baseline
3.21 (0.05)3.18 (0.07)3.24 (0.08)Week 6
aResults based on 10 multiple imputations, b coefficient combined (mean), beta coefficients as effect size, minimum and maximum across imputations,
group dummy coded with intervention=0, control=1.
Discussion
Principal Results
This randomized controlled trial investigated the effects of a
website presenting systematically collected and organized
patients’ experiences of living with colorectal cancer on
self-efficacy for coping with the disease and on patient
competencies such as coping with emotional distress or dealing
with the life threatening nature of cancer [10]. Participants
randomized to the intervention were given access to the website
for two consecutive weeks. Contrary to expectations, no
intervention effects were found at 2 and 6 weeks after baseline.
Also contrary to expectations, primary and secondary outcome
scores showed a slight but significant decrease from baseline
to follow-up measurements.
In what follows, we will briefly discuss possible explanations
for each of these observations. Insofar as these explanations
involve factors relating to characteristics of the new website
module itself or to its use by participants, they will primarily
be discussed in the section comparing these results to prior work.
In contrast, explanations that involve methodological factors
will be discussed in the limitations section. Considering these
factors in more detail may help improve the design of future
studies that aim at evaluating websites providing patient
narratives on living with (colorectal) cancer. This appears
especially important if one shares the conviction that such
narratives contain elements that are relevant for empowering
cancer patients and helping them develop their coping
competencies and coping self-efficacy.
Regarding the slight, but significant, decrease of self-efficacy
for coping with cancer and three patient competence scales
across time observed in this study, a possible explanation may
lie in assuming the operation of a response shift [52]. In the
course of the study, participants may have undergone a change
in their frames of reference for rating coping self-efficacy and
patient competencies. One may speculate, for example, that the
observed decrease might reflect some sort of disillusionment
resulting from participants’ encountering narratives that describe
coping options, which they perceived as beyond their own
repertoire of coping behaviors. Then, however, one would expect
this change not to occur in the waiting list control group, which
is not the case. Thus, this explanation appears rather unlikely.
Finally, one could argue that the observed decrease in coping
self-efficacy and competence may indicate a regression toward
the mean stemming from the self-selection of participants into
the trial who already score high on these measures at baseline.
Comparing trial participants to the sample of a previous study
[10,41] in fact shows them to score significantly higher on the
seeking information scale of the competence measure used here.
Their scores on the scales used for measuring the secondary
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outcome criteria are fairly comparable, rendering regression to
the mean an implausible explanation. The foregoing discussion
focused on possible explanations of an observed decrease in
coping self-efficacy and patient competencies. Therefore, we
would like to conclude stressing that identifying factors that
help patients’ develop their coping self-efficacy and
competencies remains an important task for future research.
Limitations
A major limitation of this study may be that its participants were
much younger on average (mean 54.1, SD 11.1 years) than
patients with colorectal cancer in Germany in general (mean 71
years) [53]. Although access to and use of the Internet is
increasing in all age groups, older patients still appear to be
active on the Web to a lesser percentage than younger patients
in Germany [54]. Therefore, including participants from this
segment of the population of colorectal cancer patients in future
research is called for to gain more insight into how websites
such as the one studied here may affect these patients. A
comparable argument would apply to the potential role of gender
in this context, which was beyond the scope of this study.
Finally, including patients’ family or friends in such a study
might add another facet to future research in this field because
these people often support patients in seeking health information
on the Internet [55].
Another important limitation may be the fact that far fewer
participants could be recruited for the study than suggested by
the initial determination of the necessary sample size. This
inevitably reduced the power of the trial to detect a treatment
effect, if it in fact existed. It would certainly have been
preferable to extend the recruitment phase of the study.
Unfortunately, this was not possible because of the timeline of
the study and the intention to make the newly constructed
website available to the public in due time. Nevertheless,
achieving the targeted sample size would by no means have
guaranteed to establish the hypothesized effect.
Comparison With Prior Work
Traditional face-to-face psychoeducational interventions in
cancer patients have been shown to yield small-to-medium
positive effects on distress and quality of life, although problems
with study quality and heterogeneity have to be acknowledged
[56-59]. Internet-based interventions targeting these domains
are gradually appearing and tend to give comparable results
[60-62]. This study extended these latter efforts to providing
scientifically based narrative information on living with
colorectal cancer online and including self-efficacy for coping
with cancer and patient competence as outcome criteria in a
randomized controlled trial. However, a feature that
distinguishes the aforementioned interventions from the website
under study is the apparent curricular structure that is typically
designed in accordance with the changes desired in the targeted
behavioral domain. Also, these interventions appear to require
more participant involvement in terms of time investment when
progressing through a series of defined tasks for one or more
weeks. In contrast, this study allowed participants to explore
the site under study according to their immediate personal goals
and preferences. As a consequence, they may have utilized the
website to a narrower extent than was theoretically possible.
The observation that participants in this study spent a limited
amount of time using the site is in line with this argument.
Therefore, more detailed analyses of patients’ website user
behaviors as a mediator of online intervention effects are called
for in future research. Beyond this, evaluating the effects of
online interventions presenting illness narratives by cancer
patients may also profit from supplementary measures of more
general psycho-oncological constructs such as the ones used
here, with measures capturing subjectively perceived effects
and changes more directly. Efforts in that direction might profit
from Pols’ research into patients’ knowledge [63,64] that aims
at a reconceptualization incorporating patients’ day-to-day
coping transactions with illness on a more specific level.
Conclusions
Regarding self-efficacy for coping with cancer and patient
competence, this study found that having access to a new
website presenting illness narratives of colorectal cancer patients
that have been systematically collected on a scientific basis has
no effect compared to a control condition. Possible explanations
of this finding may be seen in specific features of the website
itself and in features of patients’ on-site usage behavior that
might operate as a moderator of online intervention effects on
coping self-efficacy and patient competence and other
patient-reported outcomes. As a consequence, it may be of
importance to analyze patients’ usage behavior in more detail
in future research. Furthermore, future research should extend
the range of outcome criteria and include measures that more
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